Table 2.
Disease activity variables for individuals with RA
| Variable | N | |
|---|---|---|
| Disease duration from symptom start, years, mean (SD) | 121 | 14 (13) |
| VAS pain, mm, mean (SD) | 123 | 35 (28) |
| ESR, mm, mean (SD) | 123 | 19 (15) |
| CRP, mg/ml, mean (SD) | 126 | 9 (8) |
| DAS28ESR classes, % | 125 | |
| DAS28 < 2.6 remission | 40.5% | |
| 2.61–3.2 low disease activity | 22.2% | |
| 3.21–5.1 moderate disease activity | 31% | |
| > 5.1 high disease activity | 5.6.% | |
| Anti - CCP positive % | 124 | 66% |
| RF positive % | 123 | 56% |
| Number of current DMARDs, mean (SD) | 126 | 0.8 (0.6) |
| Total number of all medications at inclusion, mean (SD) | 126 | 9.9 (4.3) |
NA not available, VAS visual analogue scale, ESR Erythrocyte sedimentation rate, CRP C- reactive protein, DAS28ESR Disease Activity Score (28 joints) calculated with ESR, Anti-CCP Anti-cyclic citrullinated protein, RF Rheumatoid factor, DMARD Disease-modifying anti-rheumatic drug